General Information
Version
6.2
Revision date
2022-11-15
Product name
21-Hydroxyprogesterone
CAS No.
64-85-7
REACH No
A
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H373
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure. H351 Suspected of causing cancer.
Precautionary statements
P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
- none
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Carcinogenicity (Category 2), H351 Specific target organ toxicity - repeated exposure (Category 2), H373 For the full text of the H-Statements mentioned in this Section, see Section 16.
